Clidanac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H19ClO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UA6HM01WAK, chemically known as 6-chloro-5-cyclohexyl-2,3-dihydro-1h-indene-1-carboxylic acid but generally known as clidanac, which bears US NIH Compound Identifier 120108. European Medicines Agency schedules Clidanac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06659MIG. The term CLIDANAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). CLIDANAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clidanac under HS 29163900 and SITC 51379. As of Q4 2014, CLIDANAC remains the US FDA Preferred Term for this commodity. Clidanac bears US NLM identifiers UMLS ID C0055876 and NCI Concept Code C77342. SMILES: CLC1C(C2CCCCC2)CC2C(C(CC2)C(=O)O)C1.